New PRI Brief: JAMA Study Justifying Drug Price Controls Deeply Flawed, Patient Health Jeopardized if Findings Implemented

SACRAMENTO, Calif., May 8, 2024 /PRNewswire/ — A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute analyzes a Journal of the American Medical Association (JAMA) study cited by Sen. Bernie Sanders (I-Vermont) to…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks